In our study on 3 cases of primary CNS A-DLBCL, patients also had MYC/BCL2 co-expression, and concurrent MYC and BCL2 and/or BCL6 genetic abnormalities, and constitutive NF-κB pathway activation (4). The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.